|
1
|
Yu Q, Fan W and Cao F: Mechanistic
molecular imaging of cardiac cell therapy for ischemic heart
disease. Am J Physiol Heart Circ Physiol. 305:H947–H959. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Toyoda Y, Guy TS and Kashem A: Present
status and future perspectives of heart transplantation. Circ J.
77:1097–1110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Burchill LJ and Ross HJ: Heart
transplantation in adults with end-stage congenital heart disease.
Future Cardiol. 8:329–342. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schächinger V, Erbs S, Elsässer A, et al:
Improved clinical outcome after intracoronary administration of
bone-marrow-derived progenitor cells in acute myocardial
infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart
J. 27:2775–2783. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tse HF, Thambar S, Kwong YL, et al:
Prospective randomized trial of direct endomyocardial implantation
of bone marrow cells for treatment of severe coronary artery
diseases (PROTECT-CAD trial). Eur Heart J. 28:2998–3005. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Strauer BE and Steinhoff G: 10 years of
intracoronary and intra-myocardial bone marrow stem cell therapy of
the heart: from the methodological origin to clinical practice. J
Am Coll Cardiol. 58:1095–1104. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang YL, Tang Y, Zhang YC, Qian K, Shen L
and Phillips MI: Improved graft mesenchymal stem cell survival in
ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J
Am Coll Cardiol. 46:1339–1350. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Menasché P: Current status and future
prospects for cell transplantation to prevent congestive heart
failure. Semin Thorac Cardiovasc Surg. 20:131–137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao XS, Pan W, Bekeredjian R and Shohet
RV: Endogenous endothelin-1 is required for cardiomyocyte survival
in vivo. Circulation. 114:830–837. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fang WT, Li HJ and Zhou LS: Protective
effects of prostaglandin E1 on human umbilical vein endothelial
cell injury induced by hydrogen peroxide. Acta Pharmacol Sin.
31:485–492. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takikawa M, Sumi Y, Tanaka Y, et al:
Protective effect of pros-taglandin E1 on
radiation-induced proliferative inhibition and apoptosis in
keratinocytes and healing of radiation-induced skin injury in rats.
J Radiat Res. 53:385–394. 2012. View Article : Google Scholar
|
|
12
|
Li JH, Yang P, Li AL, Wang Y, Ke YN and Li
XL: Cardioprotective effect of liposomal prostaglandin E1 on a
porcine model of myocardial infarction reperfusion no-reflow. J
Zhejiang Univ Sci B. 12:638–643. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jia C, Dai C, Bu X, et al:
Co-administration of prostaglandin E1 with somatostatin attenuates
acute liver damage after massive hepatectomy in rats via inhibition
of inflammatory responses, apoptosis and endoplasmic reticulum
stress. Int J Mol Med. 31:416–422. 2013.
|
|
14
|
Zeng X, Yu SP, Taylor T, Ogle M and Wei L:
Protective effect of apelin on cultured rat bone marrow mesenchymal
stem cells against apoptosis. Stem Cell Res. 8:357–367. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chauvier D, Lecoeur H, Langonné A, et al:
Upstream control of apoptosis by caspase-2 in serum-deprived
primary neurons. Apoptosis. 10:1243–1259. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chalah A and Khosravi-Far R: The
mitochondrial death pathway. Adv Exp Med Biol. 615:25–45. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suen DF, Norris KL and Youle RJ:
Mitochondrial dynamics and apoptosis. Genes Dev. 22:1577–1590.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Martinou JC and Youle RJ: Mitochondria in
apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev
Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gross A, McDonnell JM and Korsmeyer SJ:
BCL-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Wang Y, Gao Y, et al: Maintenance
of high proliferation and multipotent potential of human hair
follicle-derived mesenchymal stem cells by growth factors. Int J
Mol Med. 31:913–921. 2013.PubMed/NCBI
|
|
21
|
Ding DC, Shyu WC and Lin SZ: Mesenchymal
stem cells. Cell Transplant. 20:5–14. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hale SL, Dai W, Dow JS and Kloner RA:
Mesenchymal stem cell administration at coronary artery reperfusion
in the rat by two delivery routes: a quantitative assessment. Life
Sci. 83:511–515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hodgetts SI, Beilharz MW, Scalzo AA and
Grounds MD: Why do cultured transplanted myoblasts die in vivo? DNA
quantification shows enhanced survival of donor male myoblasts in
host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell
Transplant. 9:489–502. 2000.PubMed/NCBI
|
|
24
|
Tang YL, Tang Y, Zhang YC, Qian K, Shen L
and Phillips MI: Improved graft mesenchymal stem cell survival in
ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J
Am Coll Cardiol. 46:1339–1350. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mingliang R, Bo Z and Zhengguo W: Stem
cells for cardiac repair: status, mechanisms and new strategies.
Stem Cells Int. 2011:3109282011. View Article : Google Scholar
|
|
26
|
Huang J, Zhang Z, Guo J, et al: Genetic
modification of mesenchymal stem cells overexpressing CCR1
increases cell viability, migration, engraftment, and capillary
density in the injured myocardium. Circ Res. 106:1753–1762. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang F, Zhu X, Hu XQ, et al: Mesenchymal
stem cells modified with miR-126 release angiogenic factors and
activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis
and cell survival. Int J Mol Med. 31:484–492. 2013.
|
|
28
|
Liu XB, Chen H, Chen HQ, et al:
Angiopoietin-1 preconditioning enhances survival and functional
recovery of mesenchymal stem cell transplantation. J Zhejiang Univ
Sci B. 13:616–623. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Z, Li S, Cui M, et al: Rosuvastatin
enhances the therapeutic efficacy of adipose-derived mesenchymal
stem cells for myocardial infarction via PI3K/Akt and MEK/ERK
pathways. Basic Res Cardiol. 108:3332013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dong Q, Yang Y, Song L, Qian H and Xu Z:
Atorvastatin prevents mesenchymal stem cells from hypoxia and
serum-free injury through activating AMP-activated protein kinase.
Int J Cardiol. 153:311–316. 2011. View Article : Google Scholar
|
|
31
|
Huang CL, Wu YW, Wang SS, et al:
Continuous intravenous infusion of prostaglandin E1 improves
myocardial perfusion reserve in patients with ischemic heart
disease assessed by positron emission tomography: a pilot study.
Ann Nucl Med. 25:462–468. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hara Y, Akamatsu Y, Maida K, et al: A new
liver graft preparation method for uncontrolled non-heart-beating
donors, combining short oxygenated warm perfusion and prostaglandin
E1. J Surg Res. 184:1134–1142. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma XQ, Fu RF, Feng GQ, Wang ZJ, Ma SG and
Weng SA: Hypoxia-reoxygenation-induced apoptosis in cultured
neonatal rat cardiomyocyets and the protective effect of
prostaglandin E. Clin Exp Pharmacol Physiol. 32:1124–1130. 2005.
View Article : Google Scholar
|
|
34
|
Dietrich JB: Apoptosis and anti-apoptosis
genes in the Bcl-2 family. Arch Physiol Biochem. 105:125–135.
1997.In French. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Renault TT, Teijido O, Antonsson B, Dejean
LM and Manon S: Regulation of Bax mitochondrial localization by
Bcl-2 and Bcl-x(L): keep your friends close but your enemies
closer. Int J Biochem Cell Biol. 45:64–67. 2013. View Article : Google Scholar
|
|
36
|
Degli EM and Dive C: Mitochondrial
membrane permeabilisation by Bax/Bak. Biochem Biophys Res Commun.
304:455–461. 2003. View Article : Google Scholar
|
|
37
|
Nemec KN and Khaled AR: Therapeutic
modulation of apoptosis: targeting the BCL-2 family at the
interface of the mitochondrial membrane. Yonsei Med J. 49:689–697.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Autret A and Martin SJ: Emerging role for
members of the Bcl-2 family in mitochondrial morphogenesis. Mol
Cell. 36:355–363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Garcia-Saez AJ, Fuertes G, Suckale J and
Salgado J: Permeabilization of the outer mitochondrial membrane by
Bcl-2 proteins. Adv Exp Med Biol. 677:91–105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hockenbery D, Nuñez G, Milliman C,
Schreiber RD and Korsmeyer SJ: Bcl-2 is an inner mitochondrial
membrane protein that blocks programmed cell death. Nature.
348:334–336. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Haeberlein SL: Mitochondrial function in
apoptotic neuronal cell death. Neurochem Res. 29:521–530. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mukhopadhyay A, Shishodia S, Suttles J, et
al: Ectopic expression of protein-tyrosine kinase Bcr-Abl
suppresses tumor necrosis factor (TNF)-induced NF-kappa B
activation and IkappaBalpha phosphorylation. Relationship with
down-regulation of TNF receptors. J Biol Chem. 277:30622–30628.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tan KO, Fu NY, Sukumaran SK, et al: MAP-1
is a mitochondrial effector of Bax. Proc Natl Acad Sci USA.
102:14623–14628. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Oltvai ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Heon Seo K, Ko HM, Kim HA, et al:
Platelet-activating factor induces up-regulation of antiapoptotic
factors in a melanoma cell line through nuclear factor-kappaB
activation. Cancer Res. 66:4681–4686. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lakhani SA, Masud A, Kuida K, et al:
Caspases 3 and 7: key mediators of mitochondrial events of
apoptosis. Science. 311:847–851. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhu W, Chen J, Cong X, Hu S and Chen X:
Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem
cells. Stem Cells. 24:416–425. 2006. View Article : Google Scholar
|
|
48
|
Liu HJ, Ma JW, Qiao ZY and Xu B: Study of
molecular mechanism of Prostaglandin E1 in inhibiting coronary
heart disease. Mol Biol Rep. 40:6701–6708. 2013. View Article : Google Scholar : PubMed/NCBI
|
